Disease models for the development of therapies for lysosomal storage diseases.
- Published in:
- Annals of the New York Academy of Sciences, 2016, v. 1371, n. 1, p. 15, doi. 10.1111/nyas.13052
- By:
- Publication type:
- Article
Works by Motabar, Omid
Results: 5
1
2
A high throughput glucocerebrosidase assay using the natural substrate glucosylceramide.
- Published in:
- Analytical & Bioanalytical Chemistry, 2012, v. 402, n. 2, p. 731, doi. 10.1007/s00216-011-5496-z
- By:
- Publication type:
- Article
3
Synthesis and characterization of a new fluorogenic substrate for alpha-galactosidase.
- Published in:
- Analytical & Bioanalytical Chemistry, 2009, v. 394, n. 7, p. 1903, doi. 10.1007/s00216-009-2879-5
- By:
- Publication type:
- Article
4
High Throughput Screening for Small Molecule Therapy for Gaucher Disease Using Patient Tissue as the Source of Mutant Glucocerebrosidase.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0029861
- By:
- Publication type:
- Article
5
Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article